| scholarly article | Q13442814 |
| P50 | author | Emmanuel Roilides | Q61097982 |
| Charalampos Antachopoulos | Q90292616 | ||
| Thomas J Walsh | Q108430075 | ||
| Maria Simitsopoulou | Q114417857 | ||
| Athanasios Chatzimoschou | Q114417858 | ||
| P2860 | cites work | Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms | Q21090518 |
| Responses of Pseudomonas aeruginosa to antimicrobials | Q28305587 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics | Q30874391 | ||
| Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions | Q33193706 | ||
| Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. | Q33233116 | ||
| Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia | Q33612643 | ||
| Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon | Q33618882 | ||
| Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo | Q34268901 | ||
| Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa | Q34623469 | ||
| Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin | Q34720396 | ||
| Pharmacology of amikacin in humans | Q34907857 | ||
| Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells | Q34932922 | ||
| Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
| Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients | Q35223347 | ||
| Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa | Q35661306 | ||
| Inverse regulation of biofilm formation and swarming motility by Pseudomonas aeruginosa PA14 | Q35759797 | ||
| The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections | Q36750086 | ||
| Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa | Q36757441 | ||
| Recent advances in the microbiology of respiratory tract infection in cystic fibrosis | Q37373050 | ||
| Immunomodulatory properties of antibiotics | Q37659061 | ||
| The immune system vs. Pseudomonas aeruginosa biofilms | Q37767747 | ||
| Pseudomonas aeruginosa: host defence in lung diseases | Q37781114 | ||
| Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents | Q37991389 | ||
| Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors | Q39172960 | ||
| Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms | Q40155064 | ||
| Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms | Q41503309 | ||
| Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release | Q41676362 | ||
| A new microtitre plate screening method for evaluating the viability of aerobic respiring bacteria in high surface biofilms | Q42948082 | ||
| Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin. | Q42949257 | ||
| Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa | Q43189616 | ||
| Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis | Q43257270 | ||
| Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients | Q43693161 | ||
| Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa | Q45020548 | ||
| Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent | Q45256199 | ||
| Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes | Q46149392 | ||
| Sub-inhibitory concentrations of ceftazidime and tobramycin reduce the quorum sensing signals of Pseudomonas aeruginosa | Q46446718 | ||
| Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates | Q46835624 | ||
| Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms | Q46953124 | ||
| Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms | Q50125752 | ||
| Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection. | Q51963612 | ||
| Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027. | Q52490764 | ||
| Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro. | Q54312846 | ||
| Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones. | Q54323509 | ||
| Multiple bacterial species reside in chronic wounds: a longitudinal study | Q57284132 | ||
| Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect | Q67988320 | ||
| Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis | Q69991151 | ||
| Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method | Q73729017 | ||
| In vitro activity of aminoglycosides on the respiratory burst response in human polymorphonuclear neutrophils | Q74633466 | ||
| Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects | Q94706503 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| biofilm | Q467410 | ||
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 2198-2205 | |
| P577 | publication date | 2015-02-02 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa | |
| P478 | volume | 59 |
Search more.